* Ekso Bionics Holdings Inc EKSO.OQ EKSO.O is expected
to show
a rise in quarterly revenue when it reports results on February
24.
* The Richmond California California-based company is
expected to
report a 24.2% increase in revenue to $2.8 million from $2.25
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Ekso Bionics
Holdings Inc
is for a loss of 25 cents per share. For the same quarter last
year, the company reported a loss of 48 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $11, about 78% above its last closing price
of $2.42.
This summary was machine generated February 23 at 03:03 GMT.
All figures in US dollars unless otherwise stated